Source: Annual Congress 2004 - Bronchiolitis obliterans: new developments in investigating post-transplant airway disease



Rating:

Share or cite this content

Citations should be made in the following way:
C. Ward (Newcastle upon Tyne, United Kingdom). Conclusion: new investigative tools for monitoring post-transplant airway disease. Annual Congress 2004 - Bronchiolitis obliterans: new developments in investigating post-transplant airway disease

Member's Comments

No comment yet.

Related content which might interest you: Monitoring asthma in children: clinical tools Source: International Congress 2014 – Monitoring asthma in children: results of the ERS Task Force Year: 2014 COVID-19 conundrum: clinical phenotyping based on pathophysiology as a promising approach to guide therapy in a novel illness Source: Eur Respir J, 56 (2) 2002135; 10.1183/13993003.02135-2020 Year: 2020 From the bedside: upcoming new clinical strategies: novel strategies to combat respiratory viral infections Source: International Congress 2017 – Scientific year in review Year: 2017 Bronchiectasis: state-of-the-art diagnostic and therapeutic approaches Source: Virtual Congress 2021 – Respiratory infections Year: 2021 Respiratory monitoring: revisiting classical physiological principles with new tools Source: Eur Respir J 2004; 24 : 718-719 Year: 2004 What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement Source: Eur Respir J, 52 (5) 1801261; 10.1183/13993003.01261-2018 Year: 2018 Monitoring of pulmonary function in Pompe disease: a muscle disease with new therapeutic perspectives Source: Eur Respir J 2005; 26: 984-985 Year: 2005 Non-targeted integrative multi-omics approaches on sputum reveal potential diagnostic and monitoring biomarkers for respiratory diseases Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017 From the bedside: upcoming new clinical strategies Source: International Congress 2016 – Scientific Year in Review 2016 Year: 2016 Revising our approach to conducting therapeutic clinical research in COPD Source: Eur Respir J, 51 (2) 1702712; 10.1183/13993003.02712-2017 Year: 2018 HOPE-BAL: A novel tool to expand the methodological capabilities in pulmonary research Source: Annual Congress 2012 - New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease Year: 2012 Common pitfalls in the assessment of airway disease in primary care Source: Annual Congress 2009 - Controversies in the diagnosis of asthma Year: 2009 A new era in idiopathic pulmonary fibrosis: considerations for future clinical trials Source: Eur Respir J 2015; 46: 243-249 Year: 2015